JPH10507632A - 母体からの胎児血液の濃縮 - Google Patents

母体からの胎児血液の濃縮

Info

Publication number: JPH10507632A
Authority: JP; Japan
Prior art keywords: cells; fetal; dna; suspension; cell
Prior art date: 1994-09-20
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

JP8511058A

Other languages

English (en)

Japanese (ja)

Inventor

ブッシュ，ユルゲン

ラトブルフ，アンドレアス

ミルテニー，ステファン

ホルツ，イルゲン

Original Assignee

ミルテニーバイオテック，インコーポレイティド

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-09-20

Filing date

1995-09-19

Publication date

1998-07-28

1995-09-19 Application filed by ミルテニーバイオテック，インコーポレイティド filed Critical ミルテニーバイオテック，インコーポレイティド

1998-07-28 Publication of JPH10507632A publication Critical patent/JPH10507632A/ja

Status Pending legal-status Critical Current

Links

210000004700 fetal blood Anatomy 0.000 title description 2
210000004027 cell Anatomy 0.000 claims abstract description 179
230000001605 fetal effect Effects 0.000 claims abstract description 60
238000000034 method Methods 0.000 claims abstract description 46
238000004458 analytical method Methods 0.000 claims abstract description 31
230000005291 magnetic effect Effects 0.000 claims abstract description 31
210000004369 blood Anatomy 0.000 claims abstract description 29
239000008280 blood Substances 0.000 claims abstract description 29
238000003752 polymerase chain reaction Methods 0.000 claims abstract description 24
210000003743 erythrocyte Anatomy 0.000 claims abstract description 23
108090000623 proteins and genes Proteins 0.000 claims abstract description 18
210000005087 mononuclear cell Anatomy 0.000 claims abstract description 13
239000000725 suspension Substances 0.000 claims abstract description 9
102000004169 proteins and genes Human genes 0.000 claims abstract description 8
230000002068 genetic effect Effects 0.000 claims abstract description 4
102100026144 Transferrin receptor protein 1 Human genes 0.000 claims description 37
101000835093 Homo sapiens Transferrin receptor protein 1 Proteins 0.000 claims description 36
101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 claims description 22
102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 claims description 22
239000011159 matrix material Substances 0.000 claims description 21
101000946889 Homo sapiens Monocyte differentiation antigen CD14 Proteins 0.000 claims description 13
102100035877 Monocyte differentiation antigen CD14 Human genes 0.000 claims description 13
239000000427 antigen Substances 0.000 claims description 11
108091007433 antigens Proteins 0.000 claims description 11
102000036639 antigens Human genes 0.000 claims description 11
230000002950 deficient Effects 0.000 claims description 10
230000005294 ferromagnetic effect Effects 0.000 claims description 9
230000008775 paternal effect Effects 0.000 claims description 9
210000003958 hematopoietic stem cell Anatomy 0.000 claims description 6
239000006285 cell suspension Substances 0.000 claims description 5
102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 claims description 4
101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 claims description 4
210000002593 Y chromosome Anatomy 0.000 claims description 4
238000012360 testing method Methods 0.000 claims description 3
102100032912 CD44 antigen Human genes 0.000 claims description 2
102100036008 CD48 antigen Human genes 0.000 claims description 2
101000868273 Homo sapiens CD44 antigen Proteins 0.000 claims description 2
101000716130 Homo sapiens CD48 antigen Proteins 0.000 claims description 2
101000961414 Homo sapiens Membrane cofactor protein Proteins 0.000 claims description 2
102100039373 Membrane cofactor protein Human genes 0.000 claims description 2
101710160107 Outer membrane protein A Proteins 0.000 claims description 2
230000000779 depleting effect Effects 0.000 claims 2
238000010998 test method Methods 0.000 claims 2
238000005406 washing Methods 0.000 claims 2
230000008774 maternal effect Effects 0.000 abstract description 40
239000000523 sample Substances 0.000 abstract description 20
239000011886 peripheral blood Substances 0.000 abstract description 7
239000003550 marker Substances 0.000 abstract description 6
210000005259 peripheral blood Anatomy 0.000 abstract description 6
230000002759 chromosomal effect Effects 0.000 abstract description 5
230000031864 metaphase Effects 0.000 abstract description 3
210000003924 normoblast Anatomy 0.000 abstract description 3
238000010561 standard procedure Methods 0.000 abstract description 3
230000005856 abnormality Effects 0.000 abstract description 2
238000007901 in situ hybridization Methods 0.000 abstract description 2
101150044453 Y gene Proteins 0.000 abstract 1
108020004414 DNA Proteins 0.000 description 32
108700028369 Alleles Proteins 0.000 description 28
230000007812 deficiency Effects 0.000 description 19
239000003153 chemical reaction reagent Substances 0.000 description 17
239000002245 particle Substances 0.000 description 16
239000002953 phosphate buffered saline Substances 0.000 description 13
238000001514 detection method Methods 0.000 description 12
230000027455 binding Effects 0.000 description 11
239000002609 medium Substances 0.000 description 9
210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 9
238000000926 separation method Methods 0.000 description 8
210000003754 fetus Anatomy 0.000 description 7
239000000203 mixture Substances 0.000 description 7
108010062347 HLA-DQ Antigens Proteins 0.000 description 6
239000007850 fluorescent dye Substances 0.000 description 6
239000000243 solution Substances 0.000 description 6
239000000872 buffer Substances 0.000 description 5
210000000349 chromosome Anatomy 0.000 description 5
238000000684 flow cytometry Methods 0.000 description 5
239000012634 fragment Substances 0.000 description 5
238000003199 nucleic acid amplification method Methods 0.000 description 5
238000003793 prenatal diagnosis Methods 0.000 description 5
230000000717 retained effect Effects 0.000 description 5
102100024222 B-lymphocyte antigen CD19 Human genes 0.000 description 4
101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 description 4
108091028043 Nucleic acid sequence Proteins 0.000 description 4
230000003321 amplification Effects 0.000 description 4
210000000601 blood cell Anatomy 0.000 description 4
238000006243 chemical reaction Methods 0.000 description 4
239000012141 concentrate Substances 0.000 description 4
238000001943 fluorescence-activated cell sorting Methods 0.000 description 4
238000003205 genotyping method Methods 0.000 description 4
239000006249 magnetic particle Substances 0.000 description 4
239000011325 microbead Substances 0.000 description 4
238000010186 staining Methods 0.000 description 4
108091003079 Bovine Serum Albumin Proteins 0.000 description 3
108010001682 Dextranase Proteins 0.000 description 3
SHIBSTMRCDJXLN-UHFFFAOYSA-N Digoxigenin Natural products C1CC(C2C(C3(C)CCC(O)CC3CC2)CC2O)(O)C2(C)C1C1=CC(=O)OC1 SHIBSTMRCDJXLN-UHFFFAOYSA-N 0.000 description 3
239000012591 Dulbecco’s Phosphate Buffered Saline Substances 0.000 description 3
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
101000608935 Homo sapiens Leukosialin Proteins 0.000 description 3
102100039564 Leukosialin Human genes 0.000 description 3
108010004729 Phycoerythrin Proteins 0.000 description 3
230000008901 benefit Effects 0.000 description 3
QONQRTHLHBTMGP-UHFFFAOYSA-N digitoxigenin Natural products CC12CCC(C3(CCC(O)CC3CC3)C)C3C11OC1CC2C1=CC(=O)OC1 QONQRTHLHBTMGP-UHFFFAOYSA-N 0.000 description 3
SHIBSTMRCDJXLN-KCZCNTNESA-N digoxigenin Chemical compound C1([C@@H]2[C@@]3([C@@](CC2)(O)[C@H]2[C@@H]([C@@]4(C)CC[C@H](O)C[C@H]4CC2)C[C@H]3O)C)=CC(=O)OC1 SHIBSTMRCDJXLN-KCZCNTNESA-N 0.000 description 3
238000002474 experimental method Methods 0.000 description 3
210000004698 lymphocyte Anatomy 0.000 description 3
238000007885 magnetic separation Methods 0.000 description 3
238000002360 preparation method Methods 0.000 description 3
230000008569 process Effects 0.000 description 3
230000035945 sensitivity Effects 0.000 description 3
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
206010000234 Abortion spontaneous Diseases 0.000 description 2
102100035248 Alpha-(1,3)-fucosyltransferase 4 Human genes 0.000 description 2
102100022548 Beta-hexosaminidase subunit alpha Human genes 0.000 description 2
102000017420 CD3 protein, epsilon/gamma/delta subunit Human genes 0.000 description 2
108050005493 CD3 protein, epsilon/gamma/delta subunit Proteins 0.000 description 2
102100035716 Glycophorin-A Human genes 0.000 description 2
108091005250 Glycophorins Proteins 0.000 description 2
101001022185 Homo sapiens Alpha-(1,3)-fucosyltransferase 4 Proteins 0.000 description 2
101000581981 Homo sapiens Neural cell adhesion molecule 1 Proteins 0.000 description 2
108060003951 Immunoglobulin Proteins 0.000 description 2
XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
108091092878 Microsatellite Proteins 0.000 description 2
102100027347 Neural cell adhesion molecule 1 Human genes 0.000 description 2
238000012408 PCR amplification Methods 0.000 description 2
238000010222 PCR analysis Methods 0.000 description 2
WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
239000006146 Roswell Park Memorial Institute medium Substances 0.000 description 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
229910000831 Steel Inorganic materials 0.000 description 2
208000022292 Tay-Sachs disease Diseases 0.000 description 2
208000037280 Trisomy Diseases 0.000 description 2
210000004252 chorionic villi Anatomy 0.000 description 2
238000007796 conventional method Methods 0.000 description 2
-1 dinitrophenyl Chemical group 0.000 description 2
201000010099 disease Diseases 0.000 description 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
230000009977 dual effect Effects 0.000 description 2
239000012091 fetal bovine serum Substances 0.000 description 2
239000000835 fiber Substances 0.000 description 2
239000012997 ficoll-paque Substances 0.000 description 2
239000010419 fine particle Substances 0.000 description 2
238000003306 harvesting Methods 0.000 description 2
238000009396 hybridization Methods 0.000 description 2
102000018358 immunoglobulin Human genes 0.000 description 2
208000015181 infectious disease Diseases 0.000 description 2
238000002372 labelling Methods 0.000 description 2
239000011859 microparticle Substances 0.000 description 2
208000015994 miscarriage Diseases 0.000 description 2
201000006938 muscular dystrophy Diseases 0.000 description 2
229920000642 polymer Polymers 0.000 description 2
230000035935 pregnancy Effects 0.000 description 2
XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 description 2
239000011541 reaction mixture Substances 0.000 description 2
238000011084 recovery Methods 0.000 description 2
208000007056 sickle cell anemia Diseases 0.000 description 2
239000011734 sodium Substances 0.000 description 2
208000000995 spontaneous abortion Diseases 0.000 description 2
239000010959 steel Substances 0.000 description 2
238000004448 titration Methods 0.000 description 2
210000002993 trophoblast Anatomy 0.000 description 2
230000035899 viability Effects 0.000 description 2
IJRKANNOPXMZSG-SSPAHAAFSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC(=O)CC(O)(C(O)=O)CC(O)=O IJRKANNOPXMZSG-SSPAHAAFSA-N 0.000 description 1
101150063992 APOC2 gene Proteins 0.000 description 1
102100039998 Apolipoprotein C-II Human genes 0.000 description 1
208000002109 Argyria Diseases 0.000 description 1
108090001008 Avidin Proteins 0.000 description 1
244000056139 Brassica cretica Species 0.000 description 1
235000003351 Brassica cretica Nutrition 0.000 description 1
235000003343 Brassica rupestris Nutrition 0.000 description 1
206010008805 Chromosomal abnormalities Diseases 0.000 description 1
208000031404 Chromosome Aberrations Diseases 0.000 description 1
208000027205 Congenital disease Diseases 0.000 description 1
208000029767 Congenital, Hereditary, and Neonatal Diseases and Abnormalities Diseases 0.000 description 1
102000053602 DNA Human genes 0.000 description 1
238000007400 DNA extraction Methods 0.000 description 1
LTMHDMANZUZIPE-AMTYYWEZSA-N Digoxin Natural products O([C@H]1[C@H](C)O[C@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@](C)([C@H](O)C4)[C@H](C4=CC(=O)OC4)CC5)CC3)CC2)C[C@@H]1O)[C@H]1O[C@H](C)[C@@H](O[C@H]2O[C@@H](C)[C@H](O)[C@@H](O)C2)[C@@H](O)C1 LTMHDMANZUZIPE-AMTYYWEZSA-N 0.000 description 1
241000255925 Diptera Species 0.000 description 1
201000010374 Down Syndrome Diseases 0.000 description 1
229920001917 Ficoll Polymers 0.000 description 1
229930183217 Genin Natural products 0.000 description 1
102100028972 HLA class I histocompatibility antigen, A alpha chain Human genes 0.000 description 1
102100028976 HLA class I histocompatibility antigen, B alpha chain Human genes 0.000 description 1
108010075704 HLA-A Antigens Proteins 0.000 description 1
108010058607 HLA-B Antigens Proteins 0.000 description 1
108010010378 HLA-DP Antigens Proteins 0.000 description 1
102000015789 HLA-DP Antigens Human genes 0.000 description 1
108010086786 HLA-DQA1 antigen Proteins 0.000 description 1
108010058597 HLA-DR Antigens Proteins 0.000 description 1
102000006354 HLA-DR Antigens Human genes 0.000 description 1
108091005880 Hemoglobin F Proteins 0.000 description 1
108010054147 Hemoglobins Proteins 0.000 description 1
102000001554 Hemoglobins Human genes 0.000 description 1
208000031220 Hemophilia Diseases 0.000 description 1
208000009292 Hemophilia A Diseases 0.000 description 1
HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
101000994375 Homo sapiens Integrin alpha-4 Proteins 0.000 description 1
101000914496 Homo sapiens T-cell antigen CD7 Proteins 0.000 description 1
101000934341 Homo sapiens T-cell surface glycoprotein CD5 Proteins 0.000 description 1
208000023105 Huntington disease Diseases 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
102100032818 Integrin alpha-4 Human genes 0.000 description 1
108700018351 Major Histocompatibility Complex Proteins 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
241001494479 Pecora Species 0.000 description 1
102100027208 T-cell antigen CD7 Human genes 0.000 description 1
102100025244 T-cell surface glycoprotein CD5 Human genes 0.000 description 1
208000002903 Thalassemia Diseases 0.000 description 1
108010033576 Transferrin Receptors Proteins 0.000 description 1
206010044688 Trisomy 21 Diseases 0.000 description 1
GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 1
PVNJLUVGTFULAE-UHFFFAOYSA-N [NH4+].[Cl-].[K] Chemical compound [NH4+].[Cl-].[K] PVNJLUVGTFULAE-UHFFFAOYSA-N 0.000 description 1
230000002159 abnormal effect Effects 0.000 description 1
239000002253 acid Substances 0.000 description 1
150000001447 alkali salts Chemical class 0.000 description 1
108010004469 allophycocyanin Proteins 0.000 description 1
VBIXEXWLHSRNKB-UHFFFAOYSA-N ammonium oxalate Chemical compound [NH4+].[NH4+].[O-]C(=O)C([O-])=O VBIXEXWLHSRNKB-UHFFFAOYSA-N 0.000 description 1
210000004381 amniotic fluid Anatomy 0.000 description 1
238000000137 annealing Methods 0.000 description 1
238000013459 approach Methods 0.000 description 1
239000011324 bead Substances 0.000 description 1
229960002685 biotin Drugs 0.000 description 1
235000020958 biotin Nutrition 0.000 description 1
239000011616 biotin Substances 0.000 description 1
QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 1
210000002798 bone marrow cell Anatomy 0.000 description 1
229940098773 bovine serum albumin Drugs 0.000 description 1
238000007444 cell Immobilization Methods 0.000 description 1
238000003320 cell separation method Methods 0.000 description 1
210000003850 cellular structure Anatomy 0.000 description 1
238000005119 centrifugation Methods 0.000 description 1
238000005345 coagulation Methods 0.000 description 1
230000015271 coagulation Effects 0.000 description 1
238000000576 coating method Methods 0.000 description 1
238000011109 contamination Methods 0.000 description 1
230000008878 coupling Effects 0.000 description 1
238000010168 coupling process Methods 0.000 description 1
238000005859 coupling reaction Methods 0.000 description 1
230000001351 cycling effect Effects 0.000 description 1
230000009089 cytolysis Effects 0.000 description 1
238000004163 cytometry Methods 0.000 description 1
238000007405 data analysis Methods 0.000 description 1
230000007423 decrease Effects 0.000 description 1
230000003247 decreasing effect Effects 0.000 description 1
238000004925 denaturation Methods 0.000 description 1
230000036425 denaturation Effects 0.000 description 1
238000003745 diagnosis Methods 0.000 description 1
LTMHDMANZUZIPE-PUGKRICDSA-N digoxin Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)[C@H](O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O LTMHDMANZUZIPE-PUGKRICDSA-N 0.000 description 1
229960005156 digoxin Drugs 0.000 description 1
LTMHDMANZUZIPE-UHFFFAOYSA-N digoxine Natural products C1C(O)C(O)C(C)OC1OC1C(C)OC(OC2C(OC(OC3CC4C(C5C(C6(CCC(C6(C)C(O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)CC2O)C)CC1O LTMHDMANZUZIPE-UHFFFAOYSA-N 0.000 description 1
238000010790 dilution Methods 0.000 description 1
239000012895 dilution Substances 0.000 description 1
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
BFMYDTVEBKDAKJ-UHFFFAOYSA-L disodium;(2',7'-dibromo-3',6'-dioxido-3-oxospiro[2-benzofuran-1,9'-xanthene]-4'-yl)mercury;hydrate Chemical compound O.[Na+].[Na+].O1C(=O)C2=CC=CC=C2C21C1=CC(Br)=C([O-])C([Hg])=C1OC1=C2C=C(Br)C([O-])=C1 BFMYDTVEBKDAKJ-UHFFFAOYSA-L 0.000 description 1
239000006185 dispersion Substances 0.000 description 1
229940079593 drug Drugs 0.000 description 1
239000003814 drug Substances 0.000 description 1
230000003203 everyday effect Effects 0.000 description 1
239000003302 ferromagnetic material Substances 0.000 description 1
238000012252 genetic analysis Methods 0.000 description 1
230000009395 genetic defect Effects 0.000 description 1
210000003714 granulocyte Anatomy 0.000 description 1
238000010438 heat treatment Methods 0.000 description 1
229960002897 heparin Drugs 0.000 description 1
229920000669 heparin Polymers 0.000 description 1
238000010166 immunofluorescence Methods 0.000 description 1
230000002998 immunogenetic effect Effects 0.000 description 1
238000000338 in vitro Methods 0.000 description 1
238000011065 in-situ storage Methods 0.000 description 1
229910052742 iron Inorganic materials 0.000 description 1
238000002955 isolation Methods 0.000 description 1
150000002540 isothiocyanates Chemical class 0.000 description 1
239000007788 liquid Substances 0.000 description 1
210000004185 liver Anatomy 0.000 description 1
238000011068 loading method Methods 0.000 description 1
230000002934 lysing effect Effects 0.000 description 1
230000005389 magnetism Effects 0.000 description 1
239000000463 material Substances 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
238000012986 modification Methods 0.000 description 1
230000004048 modification Effects 0.000 description 1
210000001616 monocyte Anatomy 0.000 description 1
229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
235000019796 monopotassium phosphate Nutrition 0.000 description 1
235000010460 mustard Nutrition 0.000 description 1
230000035772 mutation Effects 0.000 description 1
230000007935 neutral effect Effects 0.000 description 1
125000006501 nitrophenyl group Chemical group 0.000 description 1
210000004976 peripheral blood cell Anatomy 0.000 description 1
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
239000010452 phosphate Substances 0.000 description 1
PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
239000002504 physiological saline solution Substances 0.000 description 1
230000003169 placental effect Effects 0.000 description 1
229920002401 polyacrylamide Polymers 0.000 description 1
102000054765 polymorphisms of proteins Human genes 0.000 description 1
229910052700 potassium Inorganic materials 0.000 description 1
239000001103 potassium chloride Substances 0.000 description 1
235000011164 potassium chloride Nutrition 0.000 description 1
238000012545 processing Methods 0.000 description 1
238000000746 purification Methods 0.000 description 1
238000011002 quantification Methods 0.000 description 1
108020003175 receptors Proteins 0.000 description 1
102000005962 receptors Human genes 0.000 description 1
230000003252 repetitive effect Effects 0.000 description 1
238000011160 research Methods 0.000 description 1
238000012552 review Methods 0.000 description 1
PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
239000012266 salt solution Substances 0.000 description 1
238000013341 scale-up Methods 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
239000001488 sodium phosphate Substances 0.000 description 1
229910000162 sodium phosphate Inorganic materials 0.000 description 1
241000894007 species Species 0.000 description 1
230000009870 specific binding Effects 0.000 description 1
210000000130 stem cell Anatomy 0.000 description 1
230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 description 1
208000024891 symptom Diseases 0.000 description 1
MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 1
238000012546 transfer Methods 0.000 description 1
RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
210000003462 vein Anatomy 0.000 description 1
230000036266 weeks of gestation Effects 0.000 description 1
210000002268 wool Anatomy 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6804—Nucleic acid analysis using immunogens
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/54326—Magnetic particles
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- G01N33/56972—White blood cells
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/36—Gynecology or obstetrics
- G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Hematology (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
Urology & Nephrology (AREA)
Analytical Chemistry (AREA)
Cell Biology (AREA)
Microbiology (AREA)
Pathology (AREA)
General Health & Medical Sciences (AREA)
Physics & Mathematics (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
General Physics & Mathematics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Food Science & Technology (AREA)
Zoology (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
Wood Science & Technology (AREA)
Virology (AREA)
Biophysics (AREA)
Tropical Medicine & Parasitology (AREA)
Bioinformatics & Cheminformatics (AREA)
General Engineering & Computer Science (AREA)
Genetics & Genomics (AREA)
Gynecology & Obstetrics (AREA)
Pregnancy & Childbirth (AREA)
Reproductive Health (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

JP8511058A 1994-09-20 1995-09-19 母体からの胎児血液の濃縮 Pending JPH10507632A (ja)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US30922994A	1994-09-20	1994-09-20
US08/309,229		1994-09-20
PCT/US1995/011971 WO1996009409A1 (en)	1994-09-20	1995-09-19	Enrichment of fetal cells from maternal blood

Publications (1)

Publication Number	Publication Date
JPH10507632A true JPH10507632A (ja)	1998-07-28

Family

ID=23197274

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
JP8511058A Pending JPH10507632A (ja)	1994-09-20	1995-09-19	母体からの胎児血液の濃縮

Country Status (5)

Country	Link
EP (1)	EP0778899A4 (de)
JP (1)	JPH10507632A (de)
AU (1)	AU691040B2 (de)
CA (1)	CA2200294A1 (de)
WO (1)	WO1996009409A1 (de)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2013531259A (ja) *	2010-07-21	2013-08-01	ディアガスト	赤血球の血液型判定および表現型判定における抗体／抗原複合体の実証のための磁気的免疫診断法およびキット
JP2015501646A (ja) *	2011-12-17	2015-01-19	深▲せん▼華大基因医学有限公司	ゲノムの異常の有無を判断する方法及びシステム

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1294964B1 (it) *	1996-07-12	1999-04-23	Domenico Valerio	Isolamento e cultura di cellule fetali dal sangue periferico materno
DK0925494T3 (da)	1996-09-04	2002-07-01	Scandinavian Micro Biodevices	Mikrostrømningssystem til partikelseparation og analyse
FR2758884B1 (fr) *	1997-01-30	1999-04-02	Bio Merieux	Procede pour isoler, notamment detecter ou quantifier un analyte dans un milieu
JP2001514751A (ja) *	1997-03-08	2001-09-11	ザ・ユニバーシティー・オブ・ダンディー	胎児診断方法
GB0009179D0 (en) *	2000-04-13	2000-05-31	Imp College Innovations Ltd	Non-invasive prenatal diagnosis
GB0616045D0 (en) *	2006-08-11	2006-09-20	Univ Bristol	Blood cell separation
GB2447255A (en) *	2007-03-02	2008-09-10	Oncoprobe Ltd	Preparation of enriched target cell samples for use in a chemosensitivity assay
EP2955521A1 (de) *	2014-06-11	2015-12-16	Centre Hospitalier Universitaire Vaudois (CHUV)	Verfahren zur Trennung von Zellen
CN109718880A (zh) *	2019-02-20	2019-05-07	广州睿辰生物科技有限公司	基于双抗法分选胎儿有核红细胞额定微流控芯片及其分选方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4230685A (en) *	1979-02-28	1980-10-28	Northwestern University	Method of magnetic separation of cells and the like, and microspheres for use therein
US4452773A (en) *	1982-04-05	1984-06-05	Canadian Patents And Development Limited	Magnetic iron-dextran microspheres
CA2081203A1 (en) *	1990-04-23	1991-10-24	Ronald J. Berenson	Method for enriching fetal cells from maternal blood

1995
- 1995-09-19 EP EP95933174A patent/EP0778899A4/de not_active Withdrawn
- 1995-09-19 JP JP8511058A patent/JPH10507632A/ja active Pending
- 1995-09-19 AU AU35935/95A patent/AU691040B2/en not_active Ceased
- 1995-09-19 CA CA002200294A patent/CA2200294A1/en not_active Abandoned
- 1995-09-19 WO PCT/US1995/011971 patent/WO1996009409A1/en not_active Ceased

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2013531259A (ja) *	2010-07-21	2013-08-01	ディアガスト	赤血球の血液型判定および表現型判定における抗体／抗原複合体の実証のための磁気的免疫診断法およびキット
JP2015501646A (ja) *	2011-12-17	2015-01-19	深▲せん▼華大基因医学有限公司	ゲノムの異常の有無を判断する方法及びシステム

Also Published As

Publication number	Publication date
AU691040B2 (en)	1998-05-07
AU3593595A (en)	1996-04-09
WO1996009409A1 (en)	1996-03-28
EP0778899A4 (de)	2001-08-29
CA2200294A1 (en)	1996-03-28
EP0778899A1 (de)	1997-06-18

Publication	Publication Date	Title
EP0500727B1 (de)	1998-01-21	Ein nichtinvasives verfahren zur trennung und zum nachweis von fetaler dna
US5714325A (en)	1998-02-03	Prenatal diagnosis by isolation of fetal granulocytes from maternal blood
JP2965699B2 (ja)	1999-10-18	胎児細胞回収法
JP6310540B2 (ja)	2018-04-11	母体血液中の胎児細胞の濃縮及び同定及びこれに使用するリガンド
US7785898B2 (en)	2010-08-31	Maternal antibodies as fetal cell markers to identify and enrich fetal cells from maternal blood
US9885032B2 (en)	2018-02-06	Multisort cell separation method
US20090081689A1 (en)	2009-03-26	Reagents and methods to enrich rare cells from body fluids
US20140141997A1 (en)	2014-05-22	Foetal nucleated red blood cell detection
AU691040B2 (en)	1998-05-07	Enrichment of fetal cells from maternal blood
KR20230114327A (ko)	2023-08-01	태아 세포의 단리, 검출 및 분석을 위한 조성물 및방법
Prieto et al.	2001	Optimization of nucleated red blood cell (NRBC) recovery from maternal blood collected using both layers of a double density gradient
JPH11502106A (ja)	1999-02-23	少数細胞集団を濃縮する方法
Pongsritasana et al.	2006	Isolation of fetal nucleated red blood cell from maternal blood using immunomagnetic beads for prenatal diagnosis
AU7735201A (en)	2003-04-03	Fetal cell recovery method
AU9718698A (en)	1999-03-04	Prenatal diagnosis by isolation of fetal granulocytes from maternal blood

JPH10507632A - 母体からの胎児血液の濃縮 - Google Patents

Info

Links

Classifications

Landscapes

Applications Claiming Priority (3)

Publications (1)

Family

ID=23197274

Family Applications (1)

Country Status (5)

Cited By (2)

Families Citing this family (9)

Family Cites Families (3)

Cited By (2)

Also Published As

Similar Documents